Central Nervous System Efficacy of Aumolertinib Versus Gefitinib in Patients with Untreated, EGFR‐mutated, Advanced Non‐small Cell Lung Cancer: Data from a Randomized Phase III Trial (AENEAS) Shun Lu , Xiaorong Dong , Hong Jian , Jianhua Chen , Gongyan Chen , Yuping Sun , Yinghua Ji , Ziping Wang , Jianhua Shi , Junguo Lu , Shaoshui Chen , Dongqing Lv , Guojun Zhang , Chunling Liu , Juan Li , Xinmin Yu , Zhong Lin , Zhuang Yu , Zhehai Wang , Jiuwei Cui , Xingxiang Xu , Jian Fang , Jifeng Feng , Zhi Xu , Rui Ma , Jie Hu , Nong Yang , Xiangdong Zhou , Xiaohong Wu , Chengping Hu , Zhihong Zhang , You Lu , Yanping Hu , Liyan Jiang , Qiming Wang , Renhua Guo , Jianying Zhou , Baolan Li , Chunhong Hu , Wancheng Tong , Helong Zhang , Lin Ma , Yuan Chen , Zhijun Jie , Yu Yao , Longzhen Zhang , Jie Weng , Weidong Li , Jianping Xiong , Xianwei Ye , Jianchun Duan , Haihua Yang , Meili Sun , Hongying Wei , Jiawei Wei , Zheyu Zhang , Qiong Wu Cancer Communications（2024）
关键词
aumolertinib, brain metastasis, non-small cell lung cancer, third-generation EGFR-TKI
AI 理解论文
溯源树
样例
